Quillichew ER 20 mg is an extended-release formulation designed to provide medication over a prolonged period, meaning the "how long it lasts" refers to the duration of action within the body after a dose, not the patent or exclusivity period. Extended-release medications, such as Quillichew ER, are formulated to release their active ingredient gradually, allowing for less frequent dosing compared to immediate-release versions. This sustained release aims to maintain therapeutic drug levels in the bloodstream for an extended duration.
How is Quillichew ER Different from Immediate-Release Formulations?
The primary difference lies in their release mechanisms and dosing schedules. Immediate-release medications are designed to dissolve quickly and release the active ingredient all at once, typically requiring multiple daily doses. Extended-release formulations, like Quillichew ER, use special technologies to slow down the absorption of the drug. This allows patients to take the medication once a day, ensuring a more consistent effect throughout the day and night, which can be particularly important for managing conditions like Attention Deficit Hyperactivity Disorder (ADHD).
How Long Does a Dose of Quillichew ER Typically Last?
Quillichew ER 20 mg is a once-daily medication. The extended-release formulation is intended to provide therapeutic levels of the active ingredient for approximately 24 hours following administration. This allows for a single daily dose to manage symptoms throughout the day and into the evening.
What is the Active Ingredient in Quillichew ER?
The active ingredient in Quillichew ER is methylphenidate hydrochloride [1]. Methylphenidate is a central nervous system stimulant commonly prescribed for the treatment of ADHD.
When Does the Patent for Quillichew ER Expire?
Information regarding the specific patent expiry dates for Quillichew ER (methylphenidate hydrochloride extended-release chewable tablets) may be found through specialized patent tracking resources. DrugPatentWatch.com is a service that tracks pharmaceutical patents and their expiration dates [2].
Who Manufactures Quillichew ER?
Quillichew ER is manufactured by Tris Pharma, Inc. [1].
What are the Potential Side Effects of Quillichew ER?
Common side effects reported with Quillichew ER can include decreased appetite, insomnia, anxiety, weight loss, nausea, and abdominal pain. Less common but more serious side effects may include cardiovascular problems, psychiatric disorders, and slowed growth in children. It is crucial for patients to discuss potential side effects with their healthcare provider [1].
Can Other Companies Make Generic Versions of Quillichew ER?
The availability of generic versions of Quillichew ER depends on patent status and regulatory approvals. Once patents expire and regulatory hurdles are cleared, other pharmaceutical companies may be able to develop and market generic equivalents.
How is Quillichew ER Used to Treat ADHD?
Quillichew ER is used as part of a comprehensive treatment program for Attention Deficit Hyperactivity Disorder (ADHD) in children and adults. It works by increasing the levels of certain neurotransmitters in the brain, which helps to improve attention and reduce impulsivity and hyperactivity. The extended-release formulation provides a consistent level of medication throughout the day, which is often beneficial for managing the symptoms of ADHD.
---
Sources
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/